Lecicarbon E Co2-Laxans Drei (Sodium Hydrogen Carbonate, Sodium Dihydrogen Phosphate)

Sodium hydrogen carbonate reacts with sodium dihydrogen phosphate in the rectal cavity to produce carbon dioxide gas and increase osmotic pressure. The resulting influx of water into the colon softens feces and stimulates peristalsis, promoting bowel movements.

The appropriate dose of Lecicarbon E Co2-Laxans Drei is determined by the prescribing healthcare professional based on the patient’s condition, age, and clinical response. Patients should follow the prescriber’s instructions and not self‑adjust the amount.

Safety in pregnancy and lactation has not been fully established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this product.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives, Lecicarbon E Co2-Laxans Drei uses an osmotic mechanism, which generally results in gentler, water‑based stool softening and fewer cramping episodes. It is often preferred for bowel preparation because it produces a rapid, thorough cleansing effect without harsh stimulation.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product integrity.

The product is administered rectally, typically as an enema. The prescribed volume is inserted into the rectum using the supplied applicator, and the patient is advised to retain the solution for the time specified by the prescriber to achieve the desired effect.

Serious risks include severe dehydration, marked electrolyte disturbances such as hypernatremia, rectal bleeding, and rare allergic reactions. Patients should seek immediate medical attention if they experience persistent diarrhea, severe abdominal pain, or signs of an allergic response.

Individuals with active gastrointestinal bleeding, known hypersensitivity to any component, severe renal impairment, or uncontrolled electrolyte imbalances should avoid using this product unless directed otherwise by a qualified healthcare professional.